Oracle today announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and Monitoring Cloud Service to help manage and monitor its more than 300 clinical trials a year and continue to provide best-in-class solutions.
“Oracle Health Sciences InForm Cloud Service and Oracle Siebel Clinical Trial Management and Monitoring Cloud Service can simplify how we manage both operational and study data for in-house as well as outsourced studies,” said Rob Goodwin, vice president of Pfizer Global Product Development, Center of Excellence. “Clinical teams will be able to access study data through Oracle’s single platform cloud service, eliminating the need to send data back and forth to CROs, saving us time and reducing the cost of our clinical studies.”
By using Oracle Health Sciences InForm Cloud Service, Pfizer (pfizer.com) will be able to take advantage of over 100,000 investigator sites already trained in InForm, while increasing site data satisfaction.
The Oracle Health Sciences InForm Cloud Service will enable Pfizer to have greater control over its data and provide measurable efficiency and productivity gains in data management and remote monitoring. In addition, study templates and library management capabilities within Oracle Health Sciences InForm will enable Pfizer to accelerate the study-build process and result in faster trial implementation.
“Today, pharma companies are challenged by increasingly complex global clinical trials,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “With more than 15 years of electronic data capture experience in the clinical industry, Oracle Health Sciences helps leading pharmas such as Pfizer not only to standardize and optimize their clinical study processes, but also to be prepared with value-based clinical innovation solutions that enable them for the future of data collection.”
Oracle Health Sciences InForm Cloud Service includes both Oracle Health Sciences InForm and Oracle Health Sciences Data Management Workbench (DMW) to advance standardized end-to-end clinical data collection and management processes that help drive greater efficiencies for both internal and outsourced trials. Utilizing the platform, efficiencies can be gained through the seamless integration of Oracle Health Sciences InForm, Oracle Health Sciences Central Designer, and Oracle Health Sciences Data Management Workbench, enabling data standardization, streamlining collection, consolidation, cleaning, and transformation.
Pfizer will also use Oracle Siebel Clinical Trial Management and Monitoring Cloud Service, including Oracle Siebel Clinical Trial Management System, Oracle Health Sciences Clinical Development Analytics, and risk-based monitoring (RBM) functionality to provide new insights into trial management and help increase efficiency of the monitoring workforce. A single set of tools for internal and outsourced trials can simplify data exchange and the interface between investigator sites, CRO partners, and Pfizer. With the selection of Oracle’s platform and RBM solution, Pfizer will be able to execute risk-based monitoring through an integrated approach.
The Oracle Siebel Clinical Trial Management and Monitoring Cloud Service, which utilizes Oracle Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics, is a solution that combines standardized comprehensive clinical trial capabilities, integrated analytic tools, and data security with a cloud service that enables organizations to manage clinical trials effectively and economically, as well as improve CRO and sponsor relationships from early to late stage clinical trials.
Oracle (oracle.com) offers a comprehensive and fully integrated stack of cloud applications and platform services.
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
The following is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functionality described for Oracle's products remains at the sole discretion of Oracle Corporation.